CheA, a cytoplasmic histidine autokinase, plays a central role in the chemotactic signaling pathway of Escherichia coli. CheA autophosphorylates (12) and then donates its phosphoryl groups to two aspartate autokinases, CheY and CheB, which in turn control flagellar rotation (3, 35) and sensory adaptation (19) . The CheW protein couples CheA to the cytoplasmic signaling domains of membrane-bound chemoreceptors, forming a stable ternary complex (4, 11, 18) . These chemoreceptor complexes govern chemotactic behavior by modulating the autophosphorylation activity of CheA in response to attractant and repellent stimuli (5, 24) .
A variety of structure/function studies have shown that CheA is a modular protein (see Fig. 1 ). The catalytic or transmitter (T) domain is flanked on the C-terminal side by two domains (M and C) needed for coupling control by chemoreceptors and CheW (6) . The N terminus of the CheA molecule contains two domains (P1 and P2) involved in phosphotransfer operations. P1 contains the autophosphorylation site (His-48) (12) , whereas P2 contains a binding site(s) for CheB and CheY that facilitates the subsequent phosphotransfer reactions (17, 21, 32) . The cheA coding region also contains an internal, in-frame translational start that produces a CheA variant (CheA S ) lacking the first 98 amino acids, including His-48, the phosphorylation site (15, 30) . However, start site mutants that cannot make CheA S are fully chemotactic; thus, its signaling role is unclear (29) .
In vitro studies have demonstrated that the P1 domain interacts with at least three protein targets. P1 polypeptides can be phosphorylated in trans by CheA catalytic domains, indicating that P1 contains docking and substrate sites for interaction with the catalytic center (32) . Phosphorylated P1 fragments are also able to donate phosphates to CheB and CheY (12, 32) , suggesting that P1 specifies interaction sites for its phosphotransfer partners. Given these in vitro activities, P1 fragments might be expected to interfere with CheA autophosphorylation or phosphotransfer in vivo by competing for interaction targets. However, in a domain liberation study of CheA, Morrison and Parkinson found that P1 fragments did not inhibit chemotaxis when expressed at high levels in wild-type cells (22) . In contrast, P2 fragments were potent inhibitors of chemotaxis, evidently because they bind to CheY and prevent its interaction with the flagellar switch (22) .
The failure of liberated P1 domains to disrupt chemotactic signaling could mean that P1 polypeptides are functional in vitro but not in vivo-an interesting but unlikely scenario. Alternatively, P1 fragments may be active in vivo but are inefficient competitors of critical signaling interactions. To distinguish these possibilities, we examined the effects of P1 fragments on CheA-related signaling activities in vitro and devised in vivo assays for those same activities. Our findings indicate that P1 fragments can exchange phosphoryl groups with CheB and CheY molecules; however, in wild-type cells, these phosphotransfer reactions are too inefficient to divert CheA signaling phosphates from their CheB and CheY targets. Moreover, P1 fragments are poor substrates for transphosphorylation by CheA molecules because the resident P1 domain monopolizes the catalytic center. However, CheA molecules lacking a P1 domain in cis can phosphorylate P1 domains in trans at rates sufficient for chemotactic signaling.
MATERIALS AND METHODS
Bacterial strains and plasmids. The strains and plasmids used in this work are listed in Table 1 . The bacterial strains were all close relatives of RP437, an E. coli K-12 strain wild type for chemotaxis (27) . The cheA⌬ mutation in strain UU1118 was initially constructed by deleting codons 7-247 of the cheA gene carried by plasmid pEK46 (15) . The deletion was made by replacing a BsaBIEagI restriction fragment spanning the P1-P2 portion of the cheA coding region with a double-stranded oligonucleotide linker having a blunt BsaBI site at one end and a single-stranded EagI site at the other. The intervening sequence encoded a short polypeptide (LYPAPPA). The resulting mutation was confirmed by sequencing and transferred into the E. coli chromosome by linear transformation of strain RP9005, as previously described (29) . The cheA⌬ allele was subsequently moved to RP437 by cotransduction with the eda locus, yielding UU1118.
Plasmids used to produce CheA and various CheA fragments were derivatives of pTM30, an isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible expression vector (21, 22) . pKJ9 (CheA) carries the entire cheA coding region preceded by four in-frame codons of pTM30. The additional residues have no discernible effect on CheA autophosphorylation rate or ability to respond to chemoreceptor control (14) . pAG3 (CheA ) was constructed by deleting the cheA sequence of pKJ9 from an engineered SacII site at codon 149 through an EcoRV site at the downstream end of the coding region. pAG10 (CheA[1-149]-H48Q) was constructed by replacing an MfeI-StuI restriction fragment in pAG3 that includes the triplet coding for His-48 with the same fragment from a derivative of plasmid pDV4 that carried the H48Q allele of cheA (12) .
Media and culture conditions. T broth (10 g of tryptone and 5 g of NaCl per liter) was routinely used for growth of bacterial strains. The growth temperature was generally 35ЊC. HCG is H1 medium (1, 26) supplemented with 10 g of Casamino Acids and 4 g of glycerol per liter and was used for IPTG induction of protein synthesis. IPTG was purchased from Promega Corporation. Ampicillin was purchased from Sigma Chemical Co. and was used at a final concentration of 100 g/ml unless otherwise indicated.
Genetic methods. Phage P1 was used for transductional crosses as described previously (26) . Plasmid transformations were performed as described previously (9) .
Behavioral assays. The chemotactic abilities of strains were measured on semisolid tryptone agar (swarm) plates (10 g of tryptone, 5 g of NaCl, 2.6 g of agar per liter) as described elsewhere (26) . For strains harboring plasmids, ampicillin was added to the swarm plate at a final concentration of 50 g/ml.
Protein purification. CheA was purified from cultures of strain RP3098 carrying plasmid pAG3. Cells were grown in HCG plus 50 g of ampicillin per ml to mid-log phase, induced by the addition of IPTG to a final concentration of 200 M, and grown for an additional 4 h. The cells were harvested by centrifugation, resuspended in buffer A (50 mM Tris-HCl [pH 7.5], 5 mM EDTA, 2 mM ␤-mercaptoethanol), and passed twice through a French press (10,000 lb/in 2 ). The extracts were clarified by centrifugation at 100,000 ϫ g for 1 h and then precipitated with ammonium sulfate at 45% saturation. The precipitate was resuspended in buffer A, dialyzed against buffer A, and loaded onto a 50-ml column packed with Q-Sepharose (Sigma). After washing with 10 volumes of TEDG10 buffer (50 mM Tris-HCl [pH 7.5], 0.5 mM EDTA, 2 mM dithiothreitol, 10% [vol/vol] glycerol), the adherent protein was eluted with a 0 to 400 mM KCl gradient in TEDG10. Fractions containing CheA were pooled, concentrated, and dialyzed against TEDG10. To avoid proteolytic degradation, 1 mM phenanthroline and 1 mM phenylmethylsulfonyl fluoride were present throughout the purification.
CheA protein was purified from cultures of RP3098 carrying plasmid pKJ9 as described (13) . CheY protein was purified from cultures of RP3098 carrying plasmid pRL22 (20 Phosphorylation assays. All reactions were carried out in phosphorylation buffer (50 mM Tris-HCl [pH 7.5], 50 mM KCl, 5 mM MgCl) at room temperature. CheA autophosphorylation assays were performed as previously described (2). Phospho-CheA was purified for phosphotransfer assays as described (23) . All phosphotransfer assays between CheA or CheA and CheY or CheB also followed the general methods previously described (23) . Reactant concentrations for CheA and CheA phosphotransfer experiments are listed in the legends of Fig. 3 , 5, and 6. Transphosphorylation assays of CheA by CheA[260-537] or full-length CheA were performed in 20 l of phosphorylation buffer. After mixing of the purified proteins (reactant concentrations are given in the legend of Fig. 2 ), reactions were started by addition of ␥-32 P-labeled ATP (ϳ1,000 cpm/pmol) to a final concentration of 1 mM. At various times, 2-l reaction samples were removed and added to 10 l of sodium dodecyl sulfate (SDS) protein sample buffer (16) to stop the reaction. Reaction products were separated by electrophoresis on SDS-containing 16.5% polyacrylamide gels and quantified with a Molecular Dynamics PhosphorImager (23) .
RESULTS

Failure of liberated P1 fragments to jam chemotactic signaling in vivo.
In our initial domain liberation study of CheA, high-level expression of CheA , a P1-containing polypeptide, had no deleterious effect on the chemotactic ability of wild-type cells (22) . To confirm that P1 fragments do not block chemotactic signaling, we constructed an IPTG-inducible plasmid (pAG3) that expresses a different P1-containing polypeptide, CheA (Fig. 1) . Strain RP437 containing pAG3 formed normal chemotactic swarms at all inducer concentrations tested (up to 2 mM IPTG; data not shown). A derivative of pAG3 (pAG10) that produces CheA fragments with an H48Q replacement at the phosphorylation site in P1 also failed to inhibit the chemotactic behavior of RP437 (data not shown). At full induction, P1 expression from both plasmids accounted for at least 5% of total cell protein (data not shown); thus, their failure to inhibit chemotaxis cannot be ascribed to defects in the expression or stability of the CheA polypeptide.
Liberated P1 domains might fail to inhibit chemotactic signaling because they do not assume native structure in vivo when expressed as polypeptides. To assess the biochemical functionality of the P1 fragment made by pAG3, CheA peptides were purified and tested in vitro for three signalingrelated activities: (i) ability to serve as phosphorylation sub- This study pEK46 pUC118 motA-cheW 15 pAG13 pEK46 cheA⌬ This study a The cheA coding region in pKJ9 and its derivatives is preceded by four in-frame codons from the vector and consequently produces a CheA protein with four extra residues (MLQP) at the amino end and a fifth (V) which differs from the first residue (M) of wild-type CheA. The pKJ9 CheA protein is functionally indistinguishable from wild-type CheA both in vivo and in vitro.
FIG. 1. Structural features and functional organization of CheA and the
CheA-derived fragments used in this study. The scale at the top gives the amino acid coordinates of the three major functional regions of CheA. P1, P2, T, M, and C correspond to discrete structural or functional domains; L1 and L2 are flexible linkers (22, 28) . Amino acids at the N or C termini of various constructs that are not present in native CheA are indicated by single-letter designations. (32) (Fig. 1) . We used this transphosphorylation test to determine whether purified CheA fragments were also functional as phosphorylation substrates. CheA and CheA[260-537] fragments were mixed in the presence of ␥-32 P-labeled ATP, and the appearance of radiolabel in the P1 fragments was monitored over time (Fig. 2) . The reaction proceeded with a half-time of approximately 13 min. The initial rate slowed substantially at lower concentrations of either fragment, in agreement with a bimolecular reaction (data not shown), but was not impeded by a 20-fold excess of CheA[1-149]-H48Q (data not shown). By contrast, the rate of CheA autophosphorylation under the same reaction conditions was much faster (half-time of approximately 17 s) and essentially insensitive to dilution effects (at concentrations higher than 0.5 M), in agreement with an intramolecular reaction (data not shown). We conclude that CheA is competent as a phosphorylation substrate in vitro and presumably in vivo as well. Thus, the failure of these P1 fragments to block chemotactic signaling in vivo is probably not due to a defect in their ability to interact properly with the CheA catalytic domain.
CheA also became phosphorylated in reactions containing ATP and full-length CheA (Fig. 2) . However, the rate of phosphorylation by intact CheA was approximately eightfold lower than that by CheA[260-537], suggesting that the resident P1 domain in CheA molecules may limit access of free P1 fragments to the catalytic center. CheA-H48Q, whose P1 domain lacks a functional phosphorylation site, was not able to phosphorylate CheA fragments in trans (Fig. 2) , even though complementation tests indicate that its catalytic domain is functional (31a, 36) . This implies that transphosphorylation of P1 fragments by CheA depends on prior phosphorylation of the P1 domain in cis. Perhaps phosphorylation of the P1 in cis reduces its affinity for the catalytic center, thereby enhancing access of free P1 domains. Alternatively, the P1 in cis might relay phosphates to P1 molecules in trans through an exchange reaction.
To distinguish these possibilities, we labeled CheA molecules in an autophosphorylation reaction, purified them to remove free ATP, and tested the phosphorylated CheA for ability to donate phosphate to CheA fragments. After mixing phospho-CheA with CheA , there was no migration of phosphate label from CheA to the P1 fragment (data not shown). We conclude that the kinase activity of CheA is directly responsible for transphosphorylation of P1 fragments by wild-type CheA in vitro. Evidently, the resident P1 domain in CheA molecules blocks access of free P1 fragments to the catalytic center. This may be one reason why liberated P1 domains fail to interfere with chemotactic signaling by CheA. The transphosphorylation reaction could conceivably divert some CheA phosphates to P1 fragments in vivo but is probably too slow to have a significant physiological effect. In agreement with this view, a 40-fold molar excess of CheA (Fig. 3) . With no CheB or CheY, both phosphodonors were stable (data not shown); thus, the overall rate of substrate dephosphorylation in this assay reflects the slower of two reaction steps: (i) phosphotransfer from phospho-CheA or phospho-CheA Both CheY (Fig. 3A) and CheB ( Fig. 3B ) dephosphorylated CheA , indicating that the failure of P1 fragments to block chemotactic signaling in vivo is probably not caused by an inability to function as a donor in phosphotransfer reactions. However, CheA appeared to be a less efficient phosphodonor than full-length CheA, particularly with CheB as the phosphoacceptor. There was little rate difference with CheY as phosphoacceptor (Fig. 3A versus 3C ) because turnover of phospho-CheY is apparently the rate-limiting step in the reactions, as evidenced by the substantial buildup of label in CheY at early time points. With CheB as the phosphoacceptor, which turns over faster than CheY (7), there was little accumulation of phospho-CheB in the reactions (Fig. 3B versus D) , indicating that phosphotransfer could be the rate-limiting step. CheB dephosphorylated CheA approximately ninefold more slowly than it did CheA (Fig. 4B) , whereas the corresponding dephosphorylation rates by CheY differed by less than twofold (Fig. 4A) . Thus, phosphotransfer from CheA to CheB (and perhaps to CheY as well) is less efficient than that from CheA. This rate difference most likely reflects the presence of the P2 domain in CheA, which facilitates the phosphotransfer reaction by binding CheB and CheY.
The phosphotransfer ability of CheA indicates that this P1 fragment interacts with CheB and CheY, perhaps through specific binding contacts. If so, CheA fragments might interfere with the phosphotransfer activity of CheA by sequestering phosphoacceptors, but surprisingly, a 20-fold molar excess of CheA actually produced a substantial increase in the rate of CheA dephosphorylation by CheY (Fig.  5A ) and by CheB (Fig. 5B) . CheA[1-149]-H48Q fragments neither augmented nor inhibited the overall reaction rate (data not shown), suggesting that phosphorylation of CheA might be involved in the acceleration effect. Examination of the reaction kinetics revealed that at very early time points, a substantial proportion of the CheA label appeared in CheA (Fig. 6 ). Because CheA cannot dephosphorylate CheA in the absence of CheB or CheY (see above), it seems likely that CheA first transfers its phosphate to CheB or CheY, which in turn donate it to CheA[1-149] through a reverse phosphotransfer reaction. Thus, CheA probably accelerates the overall loss of phosphate from CheA by acting as a phosphate sink to facilitate the turnover of CheB and CheY phosphoacceptors. This effect was especially dramatic in the CheY reaction (Fig. 6A) , in which the buildup of phosphoCheY indicates that phospho-CheY hydrolysis is the rate-limiting step (see also Fig. 3 ). The effect is less dramatic in the CheB reaction (Fig. 6B) , in which the rates of CheB phosphorylation and dephosphorylation are probably similar, as evidenced by the negligible level of phospho-CheB intermediate.
Chemotactic signaling by P1 fragments in vivo. The in vitro assays described above indicate that CheA polypeptides retain the principal signaling activities ascribed to the P1 domain of CheA, namely, phosphorylation by the catalytic domain and phosphotransfer to CheB and CheY. However, CheA overexpression in wild-type cells had no effect on chemotactic behavior; thus, we cannot be certain that these P1 fragments are functional in vivo. To answer this question, we looked for cheA mutants in which expression of P1 fragments could restore chemotactic ability, presumably by relaying phosphates between CheA and CheB/CheY. Two types of mutants lacking a functional P1 domain in cis responded to free P1 fragments in trans: those which make only CheA S (Fig. 1) , owing to a nonsense mutation (cheA157 or cheA169) between the cheA translational start sites (15) ; and a strain that produces CheA⌬ , from which both the P1 and P2 domains are deleted (Fig. 1) . CheA S and CheA⌬ possess wildtype catalytic domains but lack P1 domains and cannot autophosphorylate. Importantly, both carry the C-terminal domains needed to couple CheA catalytic activity to chemoreceptor control. Upon induction, plasmid pAG3, which produces CheA , enhanced the swarm size of both types of mutants. The cooperation between CheA[1-149] and CheA⌬ was particularly dramatic and is shown in Fig. 7 . Plasmid pAG10, which produces the H48Q mutant of CheA , failed to enhance chemotaxis in either type of strain (Fig. 7) , indicating that the signaling pathway probably involves stimulus-modulated transphosphorylation of CheA by the catalytic domains of the mutant CheA molecules.
DISCUSSION
The CheA polypeptide studied in this report failed to disrupt chemotactic signaling in vivo but nevertheless exhibited several signaling-related functions in vitro (Fig. 8) Note that the CheB used in this experiment had a lower specific activity than that used in the experiment described in Fig. 3 but preferentially phosphorylates the resident P1 domain. It may be that native CheA molecules are simply folded in a way that sterically hinders access of free P1 fragments to the catalytic center. Alternatively, the P1 domain in cis, by virtue of its covalent connection, would also be expected to monopolize reversible binding interactions with the catalytic domain, effectively excluding P1 fragments in trans. Whatever the exclusion mechanism, the phosphorylation state of the P1 in cis may play a pivotal role, because CheA-H48Q failed to transphosphorylate CheA .
His to Asp phosphotransfer. Phosphorylated CheA transferred its phosphate to CheB and CheY, presumably to the target aspartate residues in these phospho-acceptors. We refer to this reaction as a phospho-His3Asp transfer (HD phosphotransfer). Previous studies described the phosphodonor ability of P1 fragments but did not examine the efficiency of the phosphotransfer reaction (12, 32) . We found that the rate of the CheA[1-149]3CheB transfer reaction was nearly 10-fold lower than that of the corresponding CheA reaction. Our assay conditions did not allow us to measure a definitive rate for phosphotransfer from CheA to CheY; however, we predict that this reaction is also less efficient because P1 fragments lack the CheB/CheY-binding P2 domain that facilitates CheA phosphotransfer reactions. It seems unlikely that P1 fragments bind tightly to their phosphotransfer targets, because CheA[1-149]-H48Q did not competitively interfere with the CheA transfer reaction. The nature of the recognition determinants that promote interaction of a P2-less donor fragment with target CheB or CheY molecules is not known, but several cheA mutations that affect relative CheB/CheY phosphotransfer efficiency lie close to His-48 (12, 25) . It may be that P1 phosphodonor ability is primarily a function of surface contour around the phosphohistidine, which would dictate its accessibility to productive collisions with phosphoacceptor proteins.
Asp-to-His phosphotransfer. CheA[1-149] also accepted phosphate from phospho-CheB and phospho-CheY. We refer to this reaction as a phospho-Asp3His transfer (DH phosphotransfer). The phosphotransfer equilibria for histidine kinases, including CheA, greatly favor the forward reaction under physiological conditions (31); thus, the reverse reaction detected in our assays may reflect the considerable molar excess of CheA fragments used in the reactions. Moreover, the catalytic domain of histidine kinases may play an active role in inhibiting the docking interactions or catalytic events needed for a reverse phosphotransfer reaction. Dutta and Inouye showed, for example, that a particular catalytic defect in the EnvZ kinase enabled the mutant enzyme to accept phosphate from phospho-OmpR, normally its phosphotransfer target (10) . Thus, the lack of an adjoining catalytic domain in P1 fragments of CheA could conceivably augment DH phosphotransfer. A kinase-independent DH phosphotransfer probably occurs between Spo0F and Spo0B of the sporulation signaling pathway in Bacillus subtilis (8) . DH phosphotransfers have also been reported in the ArcB-ArcA (33) and BvgS-BvgA (34) signaling systems.
Why don't liberated P1 fragments jam chemotactic signaling? The transphosphorylation and phosphotransfer capabilities of CheA indicate that this P1 fragment interacts with CheB, CheY, and the catalytic domain of CheA. The inability of CheA -H48Q fragments to interfere with the in vitro activities of CheA implies that the binding contacts that promote these signaling transactions are relatively weak ones. Thus, CheA fragments cannot compete effectively with CheA for common binding targets. In addition, local concentration effects probably allow the resident P1 domain in CheA molecules to monopolize the catalytic center, thereby preventing free P1 fragments from impairing the autophosphorylation reaction. Moreover, without the P2 domain dedicated to CheB/CheY binding, P1 fragments cannot sequester the phosphoacceptor targets of CheA and thus cannot reduce CheA phosphotransfer rates. The inability of liberated P1 domains to promote tight binding interactions with CheA, CheB, and CheY is probably the principal reason for their failure to disrupt chemotactic signaling.
CheA fragments clearly have the potential to divert in vivo phosphate fluxes from their normal signaling routes, but the relatively low rates of the detour reactions probably mitigate their behavioral consequences. For example, the transphosphorylation of P1 fragments by CheA has negligible impact on CheA autophosphorylation rate. Moreover, the P1 phosphates should then transfer to their intended targets, CheB and CheY, in any event. The DH phosphotransfer activity of P1 fragments could conceivably perturb signaling in two ways: (i) by reducing the steady-state phosphorylation level of CheY and CheB; and (ii) by creating a reservoir of phosphoryl groups available for subsequent transfer to CheB and CheY. Thus, DH phosphotransfers might dampen stimulusinduced fluctuations in phospho-CheB and -CheY levels by slowing irreversible (hydrolytic) dephosphorylation of CheB and CheY. The feedback circuitry of the sensory adaptation system would be expected to counter these P1 effects. For example, whenever steady-state phospho-CheB levels drop below a hard-wired optimum set-point, receptor methylation would rise, increasing the autophosphorylation rate of CheA and consequently the flow of phosphate to CheB (and CheY).
The possibility that CheA does not have these signaling activities in vivo can be ruled out because liberated fragments support chemotaxis in strains with mutant CheA molecules lacking P1 domains of their own. In such strains, CheA probably serves as a substrate for transphosphorylation by the CheA catalytic domain and then transfers those phosphates to CheB and CheY. Although these P1 signaling reactions are intrinsically inefficient, the overall flux of phosphate is presumably augmented to levels sufficient for chemotaxis by mass action of the many P1 fragments in the cell. Indeed, high-level expression of CheA was essential for chemotactic ability. This functional complementation system offers a means for obtaining and characterizing mutations that affect the substrate or transfer properties of P1 fragments and will enable us to identify the structural determinants needed for these CheA signaling activities.
